[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@MSollender](/creator/twitter/MSollender) "(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE" [X Link](https://x.com/MSollender/status/1940005423534547058) [@MSollender](/creator/x/MSollender) 2025-07-01T11:11Z 13.6K followers, 71K engagements "(1/3) It's the home stretch for 2025 already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK" [X Link](https://x.com/MSollender/status/1973339349103288786) [@MSollender](/creator/x/MSollender) 2025-10-01T10:48Z 13.6K followers, 20.2K engagements "(2/3) Some intriguing make-or-break data sets for companies as well as some modality readouts are upcoming $DRUG $DYN $ELDN $EWTX $FGEN $FULC $GPCR $IFRX $IMNM $IMVT $INCY $INSM $IRON $JANX $JAZZ $KRRO $LXEO $MIST $MLTX $MREO $MRSN $NKTR" [X Link](https://x.com/MSollender/status/1973339816294285641) [@MSollender](/creator/x/MSollender) 2025-10-01T10:50Z 13.6K followers, 4193 engagements "$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion" [X Link](https://x.com/MSollender/status/1924617438211277122) [@MSollender](/creator/x/MSollender) 2025-05-20T00:05Z 13.6K followers, 58.5K engagements "$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis" [X Link](https://x.com/MSollender/status/1943039211726344343) [@MSollender](/creator/x/MSollender) 2025-07-09T20:07Z 13.6K followers, 16.8K engagements "$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)" [X Link](https://x.com/MSollender/status/1943770441400955246) [@MSollender](/creator/x/MSollender) 2025-07-11T20:32Z 13.6K followers, 18.4K engagements "$CLDX Celldex Reports Results from Phase X Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver in EoE" [X Link](https://x.com/MSollender/status/1957896097508274468) [@MSollender](/creator/x/MSollender) 2025-08-19T20:03Z 13.6K followers, 9024 engagements "$PALI Palisade Bio Announces Closing of Upsized $XXX Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option" [X Link](https://x.com/MSollender/status/1973842600017998139) [@MSollender](/creator/x/MSollender) 2025-10-02T20:08Z 13.6K followers, 7000 engagements "$OVID Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $XXX Million in Gross Proceeds" [X Link](https://x.com/MSollender/status/1974069746439238025) [@MSollender](/creator/x/MSollender) 2025-10-03T11:11Z 13.6K followers, 4741 engagements "$BMEA Offering 🫠" [X Link](https://x.com/MSollender/status/1975294875655675982) [@MSollender](/creator/x/MSollender) 2025-10-06T20:19Z 13.6K followers, 8269 engagements "@jq1234t Next one is $16B at this rate" [X Link](https://x.com/MSollender/status/1973857413507002711) [@MSollender](/creator/x/MSollender) 2025-10-02T21:07Z 13.6K followers, 1442 engagements "$GLTO $ACXP $XBIO What are we doing here" [X Link](https://x.com/MSollender/status/1975844511038546426) [@MSollender](/creator/x/MSollender) 2025-10-08T08:43Z 13.6K followers, 6794 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MSollender
"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"
X Link @MSollender 2025-07-01T11:11Z 13.6K followers, 71K engagements
"(1/3) It's the home stretch for 2025 already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK"
X Link @MSollender 2025-10-01T10:48Z 13.6K followers, 20.2K engagements
"(2/3) Some intriguing make-or-break data sets for companies as well as some modality readouts are upcoming $DRUG $DYN $ELDN $EWTX $FGEN $FULC $GPCR $IFRX $IMNM $IMVT $INCY $INSM $IRON $JANX $JAZZ $KRRO $LXEO $MIST $MLTX $MREO $MRSN $NKTR"
X Link @MSollender 2025-10-01T10:50Z 13.6K followers, 4193 engagements
"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"
X Link @MSollender 2025-05-20T00:05Z 13.6K followers, 58.5K engagements
"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"
X Link @MSollender 2025-07-09T20:07Z 13.6K followers, 16.8K engagements
"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"
X Link @MSollender 2025-07-11T20:32Z 13.6K followers, 18.4K engagements
"$CLDX Celldex Reports Results from Phase X Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver in EoE"
X Link @MSollender 2025-08-19T20:03Z 13.6K followers, 9024 engagements
"$PALI Palisade Bio Announces Closing of Upsized $XXX Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option"
X Link @MSollender 2025-10-02T20:08Z 13.6K followers, 7000 engagements
"$OVID Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $XXX Million in Gross Proceeds"
X Link @MSollender 2025-10-03T11:11Z 13.6K followers, 4741 engagements
"$BMEA Offering 🫠"
X Link @MSollender 2025-10-06T20:19Z 13.6K followers, 8269 engagements
"@jq1234t Next one is $16B at this rate"
X Link @MSollender 2025-10-02T21:07Z 13.6K followers, 1442 engagements
"$GLTO $ACXP $XBIO What are we doing here"
X Link @MSollender 2025-10-08T08:43Z 13.6K followers, 6794 engagements
/creator/twitter::1063180083769176064/posts